Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Stopped Regulatory authorities did not allow the entrance of the study drug in the country
Conditions
- Spinocerebellar Ataxia Type 3
Interventions
- DRUG: Placebo
- DRUG: Sodium Phenylbutyrate
Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators